Dr José Nasser MD PHD Substack

Dr José Nasser MD PHD Substack

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA e FENBENDAZOL - Paciente com câncer de cólon estágio 4 de 60 anos com metástases hepáticas vê queda de 90% nas moléculas tumorais médias no teste Signatera em 3 meses!

Depoimento de IVERMECTINA e FENBENDAZOL …

Dr J Nasser MD and PHD
Dec 1, 2024

Share this post

Dr José Nasser MD PHD Substack
Dr José Nasser MD PHD Substack
Depoimento de IVERMECTINA e FENBENDAZOL - Paciente com câncer de cólon estágio 4 de 60 anos com metástases hepáticas vê queda de 90% nas moléculas tumorais médias no teste Signatera em 3 meses!
1

This thread is only visible to paid subscribers of Dr José Nasser MD PHD Substack

Subscribe to view →

Keep reading with a 7-day free trial

Subscribe to Dr José Nasser MD PHD Substack to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 jose augusto nasser md phd
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share